Diaminopyrimidine Synthesis Removing Unstable Intermediate
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing processes for preparing diaminopyrimidine derivatives as 5-HT4 receptor agonists face issues with instability and low yield due to the use of intermediate compounds that are difficult to handle and produce structural isomeric impurities, making them unsuitable for industrial mass production.
Innovation Solution
A novel process is developed that forms a pyrimidine ring from a substituted phenylguanidine derivative, activates it, and reacts it with (S)-3-acetamidopyrrolidine to produce the diaminopyrimidine derivative, avoiding the unstable intermediate and enabling high-yield, high-purity production suitable for industrial use, along with isolating stable crystalline forms of the hydrochloride.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If the compound of Formula (II) is prepared through performing the reaction with an excess POCl3 at a high temperature of 100° C. or higher, then the compound of Formula (II) is obtained, but impurities are produced in high level and the compound is unstable at room temperature
Solution Approach 1:
The patent removes the unstable compound of Formula (II) from the synthetic pathway entirely. Instead of preparing and isolating this unstable intermediate, the invention directly couples compounds of Formula (III) and (IV) to form the final product of Formula (I), thereby eliminating the stability problem associated with Formula (II) while maintaining production efficiency
Solution Approach 2:
The patent performs preliminary preparation of compounds of Formula (III) and (IV) in advance, ensuring they are stable and ready for the final coupling reaction. This allows the unstable intermediate step to be bypassed entirely, as the necessary precursors are prepared separately under stable conditions before the final product formation
2Ease of operation
If the compound of Formula (II) is obtained in the form of oil and handled at room temperature, then the reaction can proceed, but the compound is readily decomposed causing low stability
Solution Approach 1:
The patent extracts the problematic unstable intermediate (Formula (II)) from the reaction pathway. By directly coupling compounds of Formula (III) and (IV), the invention eliminates the need to handle the unstable oily intermediate, thereby resolving both the ease of operation and stability issues simultaneously
Solution Approach 2:
The patent adopts a strategy of not isolating or storing the unstable intermediate at all. Instead, the synthesis proceeds through direct coupling where the unstable intermediate would form transiently if at all, but is immediately consumed in the final product formation. This eliminates the need for stable isolation and handling of short-lived intermediates
3Productivity
If the compound of Formula (II) reacts with compound of Formula (III) at two reactive sites (2 and 4 positions), then the reaction proceeds, but structural isomeric impurity is produced in significant level
Solution Approach 1:
The patent modifies the local reactivity characteristics by using compounds of Formula (III) and (IV) that have specific reactive sites predetermined for coupling. This ensures that the reaction occurs at the correct position (position 2 of the pyrimidine ring) with high selectivity, preventing isomeric impurity formation while maintaining efficient reaction rates
Solution Approach 2:
The patent introduces compounds of Formula (III) and (IV) as stable intermediaries that control the regioselectivity of the final coupling reaction. These intermediaries are designed with specific functional groups that direct the reaction to occur only at the desired position, acting as mediators that prevent unwanted isomeric side reactions
4Productivity
If the compound of Formula (IV) reacts with compound of Formula (V), then the compound of Formula 1 is prepared, but the compound of Formula (V) has genetic toxicity and requires column chromatography purification
Solution Approach 1:
The patent removes the toxic compound of Formula (V) from the synthetic pathway. Instead of using this toxic reagent to prepare compound of Formula (IV), the invention prepares compound of Formula (IV) through alternative non-toxic routes, thereby eliminating the genetic toxicity hazard while maintaining the ability to produce the final product
Solution Approach 2:
The patent converts the harmful synthetic route involving toxic compounds into a beneficial non-toxic pathway. By using alternative reagents and reaction conditions that avoid genetically toxic substances, the invention maintains production efficiency while eliminating the need for extensive purification and reducing safety hazards
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The new process achieves high yield and purity, and the crystalline forms exhibit excellent stability, overcoming the limitations of the amorphous forms in terms of storage and handling.
Implementation Method 1
reacting a compound of Formula (I) with POCl3 to prepare a compound of Formula (II)
Implementation Method 2
reacting the compound of Formula (II) with a compound of Formula (III) under the presence of a base to prepare a compound of Formula (IV)
Implementation Method 3
reacting the compound of Formula (IV) with a compound of Formula (V) to prepare the compound of Formula 1
Implementation Method 4
reacting the compound of Formula 1 with hydrochloric acid in ethyl acetate
Data Source
AI summary
The present invention provides a novel process for preparing a diaminopyrimidine derivative or acid addition salt thereof having an activity as a 5-HT4 receptor agonist. And also, the present invention provides novel crystalline forms of a hydrochloride of the diaminopyrimidine derivative and processes for preparing the same.